Literature DB >> 25330246

D4 dopamine receptor-specific antagonist improves reversal learning impairment in amphetamine-treated male rats.

Nina P Connolly1, Maria Gomez-Serrano1.   

Abstract

The Attentional Set-Shifting Task (ASST) is a rodent analog of the Wisconsin Card Sorting Task, which measures executive functioning. The ASST tests for reversal of stimulus-response learning and the formation and maintenance of attentional sets. Depletion of dopamine has been shown to improve performance on attentional shifts. The study presented here questioned whether a D₄-specific antagonist, L-745,870, could have a similar effect on animals, even after being treated with repeated doses of amphetamine. Three groups of male rats were given either 10 saline injections (n = 12), 10 amphetamine injections (2 mg/kg; n = 8), or 10 amphetamine injections plus 1 pretreatment injection of L-745,870 (0.1 mg/kg; n = 8) 20 min prior to testing. One-way ANOVA results showed that amphetamine-only rats were impaired on all 3 reversals (Ms = 19, 16.4, and 17.1) compared with L-745,870-treated rats (Ms = 9.8, 10.9, and 9.6) and controls (Ms = 8.6, 9.6, 9.3; all ps < .01). L-745,870-treated rats also displayed reduced latencies to respond compared with both saline controls and amphetamine rats. It is thought that D₄ receptors play a role in cue salience, and that by blocking these receptors, animals display less attachment to previously rewarded cues. The results presented support this idea and imply that blocking of D₄ receptors can reverse the impairment in reversals caused by amphetamine. PsycINFO Database Record (c) 2014 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25330246     DOI: 10.1037/a0038216

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  1 in total

1.  Individual differences in impulsive action and dopamine transporter function in rat orbitofrontal cortex.

Authors:  J R Yates; M Darna; J S Beckmann; L P Dwoskin; M T Bardo
Journal:  Neuroscience       Date:  2015-11-23       Impact factor: 3.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.